Jonathan A. Gutman

11.2k total citations · 4 hit papers
120 papers, 6.7k citations indexed

About

Jonathan A. Gutman is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jonathan A. Gutman has authored 120 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Hematology, 28 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Jonathan A. Gutman's work include Hematopoietic Stem Cell Transplantation (38 papers), Acute Myeloid Leukemia Research (38 papers) and Acute Lymphoblastic Leukemia research (17 papers). Jonathan A. Gutman is often cited by papers focused on Hematopoietic Stem Cell Transplantation (38 papers), Acute Myeloid Leukemia Research (38 papers) and Acute Lymphoblastic Leukemia research (17 papers). Jonathan A. Gutman collaborates with scholars based in United States, Spain and Denmark. Jonathan A. Gutman's co-authors include Thomas J. Reynolds, Daniel A. Pollyea, Colleen Delaney, Clayton A. Smith, Craig T. Jordan, Frederick R. Appelbaum, Peter J. Fagenholz, N. Stuart Harris, Alice F. Murray and Amanda Winters and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Personality and Social Psychology and Nature Medicine.

In The Last Decade

Jonathan A. Gutman

117 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Means-End Chain Model Based on Consumer Categorization Processes

1982 1.5k citations Jonathan A. Gutman Journal of Marketing profile →
Laddering theory, method, analysis, and interpretation.

2001 1.1k citations Thomas J. Reynolds, Jonathan A. Gutman Journal of Advertising Research profile →
A Means-End Chain Model Based on Consumer Categorization Processes

1982 888 citations Jonathan A. Gutman Journal of Marketing profile →
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

2018 481 citations Daniel A. Pollyea, Brett M. Stevens et al. Nature Medicine profile →

Peers

Countries citing papers authored by Jonathan A. Gutman

Since Specialization

Citations

This map shows the geographic impact of Jonathan A. Gutman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Gutman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Gutman more than expected).

Fields of papers citing papers by Jonathan A. Gutman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A. Gutman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Gutman. The network helps show where Jonathan A. Gutman may publish in the future.

Co-authorship network of co-authors of Jonathan A. Gutman

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan A. Gutman. A scholar is included among the top collaborators of Jonathan A. Gutman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan A. Gutman. Jonathan A. Gutman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of CD19 CAR-T Cells in Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL) with Minimal Residual Disease (MRD) Positivity at First Complete Remission: Preliminary Outcomes from a Phase I Clinical Trial 2024 ·Blood ·Marc Schwartz, Navin Pinto, Jonathan A. Gutman, Michael R. Verneris, (unknown), (unknown), Dina Schneider, Terry J. Fry	0
2	P95 First two US patients with lupus nephritis (LN) treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy: preliminary results from the KYSA-1 phase 1, multicenter study of KYV-101 2024 ·SHILAP Revista de lepidopterología ·Amber S. Podoll, Richard Furie, Francis Kim, Justin Chou, Ranjita Sengupta, (unknown), Jonathan A. Gutman, James Chung	1
3	Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine 2023 ·Haematologica ·Amanda Winters, Mohd Minhajuddin, Brett M. Stevens, Ajay Major, (unknown), Diana Abbott, (unknown), (unknown), (unknown), Bradford Siegele, Mark D. Ewalt, Jonathan A. Gutman, Craig T. Jordan, Daniel A. Pollyea	5
4	Cytomegalovirus Immune reconstitution in cord blood transplant recipients on letermovir prophylaxis 2023 ·Transplant Infectious Disease ·Maheen Z. Abidi, Kyle C. Molina, (unknown), Jonathan A. Gutman, Adriana Weinberg	1
5	Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population 2019 ·Biology of Blood and Marrow Transplantation ·Taylor Morrisette, (unknown), Matthew A. Miller, Scott W. Mueller, Valida Bajrovic, Maheen Z. Abidi, Esther Benamu, (unknown), Gerard R. Barber, (unknown), Jennifer Tobin, Douglas N. Fish, Jonathan A. Gutman	30
6	Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia breakdown → 2018 ·Nature Medicine ·Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones, Amanda Winters, Shanshan Pei, Mohammad Minhajuddin, Angelo D’Alessandro, Rachel Culp‐Hill, Kent Riemondy, Austin E. Gillen, Jay R. Hesselberth, Diana Abbott, (unknown), Jonathan A. Gutman, Enkhtsetseg Purev, Clayton A. Smith, Craig T. Jordan	481
7	Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison 2018 ·Biology of Blood and Marrow Transplantation ·(unknown), Daniel A. Pollyea, Clayton A. Smith, Enkhtsetseg Purev, Manali Kamdar, Bradley M. Haverkos, Daniel W. Sherbenou, Rachel Rabinovitch, Andrew Hammes, Jonathan A. Gutman	6
8	Relapsed Acute Myeloid Leukemia Is Less Sensitive to Venetoclax + Azacitidine Due to Leukemia Stem Cell Resistance Driven By Fatty Acid Metabolism and Can be Overcome By Pharmacologic Inhibition of CPT1 2018 ·Blood ·Daniel A. Pollyea, Courtney L. Jones, Brett M. Stevens, Shanshan Pei, Angelo D’Alessandro, Rachel Culp‐Hill, Diana Abbott, Andrew Hammes, (unknown), Jonathan A. Gutman, Enkhtsetseg Purev, Clayton A. Smith, Craig T. Jordan	5
9	Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells 2016 ·Journal of Biological Chemistry ·Shanshan Pei, Mohammad Minhajuddin, Angelo D’Alessandro, Travis Nemkov, Brett M. Stevens, Biniam Adane, Nabilah Khan, Fred K. Hagen, Vinod Kumar Yadav, Subhajyoti De, John M. Ashton, Kirk C. Hansen, Jonathan A. Gutman, Daniel A. Pollyea, Peter A. Crooks, Clayton A. Smith, Craig T. Jordan	33
10	Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood 2010 ·Blood ·Claudio G. Brunstein, Jonathan A. Gutman, Daniel J. Weisdorf, Ann E. Woolfrey, Todd E. DeFor, Theodore A. Gooley, Michael R. Verneris, Frederick R. Appelbaum, John E. Wagner, Colleen Delaney	311
11	Closing the Gap: The Patient-Physician Disconnect 2009 ·Health Marketing Quarterly ·George Miaoulis, Jonathan A. Gutman, (unknown)	13
12	Evidence for Increased Intracranial Pressure in High Altitude Pulmonary Edema 2007 ·High Altitude Medicine & Biology ·Peter J. Fagenholz, Jonathan A. Gutman, Alice F. Murray, Vicki E. Noble, Carlos A. Camargo, N. Stuart Harris	11
13	Laddering theory, method, analysis, and interpretation. breakdown → 2001 ·Journal of Advertising Research ·Thomas J. Reynolds, Jonathan A. Gutman	1124
14	Advertising Is Image Management 2001 ·Journal of Advertising Research ·Thomas J. Reynolds, Jonathan A. Gutman	139
15	Integrating Cues into Means-End Chain Models 1997 ·Journal of Promotion Management ·Jonathan A. Gutman, Russell I. Haley	1
16	A Means-End Chain Model Based on Consumer Categorization Processes breakdown → 1982 ·Journal of Marketing ·Jonathan A. Gutman	1489
17	A Means-End Model For Facilitating Analyses of Product Markets Based on Consumer Judgement 1981 ·ACR North American Advances ·Jonathan A. Gutman	12
18	Equivalence Range in Categorization 1980 ·ACR North American Advances ·Jonathan A. Gutman	1
19	Value Structures and Consumer Behavior 1979 ·ACR North American Advances ·Jonathan A. Gutman, Donald E. Vinson	11
20	A Reinterpretation of Farley and Ring's test of the Howard-Sheth Model of Buyer Behavior 1974 ·ACR North American Advances ·(unknown), Jonathan A. Gutman	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact